As Daiichi Sankyo Takes Over Ranbaxy Reins, Japan’s Nippon Chemiphar May Exit Joint Venture
This article was originally published in The Pink Sheet Daily
Executive Summary
Ranbaxy owns half of Nippon Chemiphar subsidiary Nihon, with which it had planned to be influential in the Japanese generics market.